Chemotherapy News and Research

Latest Chemotherapy News and Research

Docetaxel decreases the chance of dying by 24 percent in advanced-stage prostate cancer patients resistant to hormone therapy

Docetaxel decreases the chance of dying by 24 percent in advanced-stage prostate cancer patients resistant to hormone therapy

Blood test that can detect amplification of a certain gene found in cells associated with breast cancer

Blood test that can detect amplification of a certain gene found in cells associated with breast cancer

Non-aspirin pain drugs may help men with recurrent prostate cancer

Non-aspirin pain drugs may help men with recurrent prostate cancer

New drugs ease treatment of multiple myeloma

New drugs ease treatment of multiple myeloma

Gemcitabine/paclitaxel combination helps breast cancer patients live longer

Gemcitabine/paclitaxel combination helps breast cancer patients live longer

New blood test may help detect breast cancer

New blood test may help detect breast cancer

SU11248 proves effective in the treatment of gastrointestinal stromal tumors

SU11248 proves effective in the treatment of gastrointestinal stromal tumors

Elderly leukemia patients benefit from intensive treatment

Elderly leukemia patients benefit from intensive treatment

Chemotherapy regimen more effective and more toxic in Japanese patients than in American patients

Chemotherapy regimen more effective and more toxic in Japanese patients than in American patients

Atrasentan reduces cancer risk by 20 percent in men with advanced hormone-resistant prostate cancer

Atrasentan reduces cancer risk by 20 percent in men with advanced hormone-resistant prostate cancer

A biological agent used without chemotherapy appears to offer a disease-free future to patients with rare leukemia

A biological agent used without chemotherapy appears to offer a disease-free future to patients with rare leukemia

Herceptin shows real promise in treatment of HER-2 positive breast disease

Herceptin shows real promise in treatment of HER-2 positive breast disease

Serum estrogen receptor modulator's (SERM's) may help reduce postmenopausal breast cancer risk

Serum estrogen receptor modulator's (SERM's) may help reduce postmenopausal breast cancer risk

Gemcitabine may help breast cancer patients with advanced disease live longer

Gemcitabine may help breast cancer patients with advanced disease live longer

Multi-targeted anticancer drug shows promise as treatment for metastatic renal cell cancer

Multi-targeted anticancer drug shows promise as treatment for metastatic renal cell cancer

Drug Tarceva improves survival chance for patients with advanced lung cancer

Drug Tarceva improves survival chance for patients with advanced lung cancer

New generation drug therapy targets the individual

New generation drug therapy targets the individual

Drug helps patients with metastatic colorectal cancer

Drug helps patients with metastatic colorectal cancer

Umbilical cord blood and bone marrow transplants slow the progression of many cancers

Umbilical cord blood and bone marrow transplants slow the progression of many cancers

Drug to extend lives of colorectal cancer patients

Drug to extend lives of colorectal cancer patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.